Assignee
NANJING GENELEAP BIOTECHNOLOGY CO LTD
CN·1 granted patent·3 pending applications·0 citations·filing 2022–2023
Top patents by PatentIndex Score
4 records- 0160US11951120B2Modification of gene transcription and translation efficiency by 5′UTR sequence variationNANJING GENELEAP BIOTECHNOLOGY CO LTD·Filed 2022·Granted Apr 9, 2024·0 cites·20 claims
- 0254US2022298508A1Galnac cluster phosphoramidite and targeted therapeutic nucleosidesNANJING GENELEAP BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0353US2023250127A1MODIFIED mRNA 5'-CAP ANALOGSNANJING GENELEAP BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0450US2025171513A9A 5'-CAP ANALOG MODIFIED mRNANANJING GENELEAP BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NANJING GENELEAP BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →